Skip to Main Content

Author Details

Patrick G Buckley
Beaumont Hospital
2002
52
26
PMIDPaper TitleJournal TitlePublished Year
36460769Personalized health risk assessment based on single-cell RNA sequencing analysis of a male with 45, X/48, XYYY karyotype.Sci Rep2022
35768433High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing.NPJ Breast Cancer2022
32088416Expansion of the phenotype of biallelic variants in TRIT1.Eur J Med Genet2020
29961873Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.J Natl Cancer Inst2019
29264834Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol.J Neurooncol2018
30054533Immunophenotyping and transcriptional profiling of in vitro cultured human adipose tissue derived stem cells.Sci Rep2018
29770897Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.J Neurooncol2018
29432475High-Throughput Tabular Data Processor - Platform independent graphical tool for processing large data sets.PLoS One2018
29595124Absence of 1p/19q codeletion in oligodendroglioma-like areas of pilocytic astrocytomas.Clin Neuropathol2018
29350171The DNA copy number landscape of a collision tumor.Clin Neuropathol2018
32913965Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities.JCO Precis Oncol2017
25137037Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.Int J Cancer2015
26219265Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.Hum Mutat2015
25960282The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.Cancer Lett2015
24299514miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency.Am J Respir Crit Care Med2014
24986208Genetic features of oligodendrogliomas and presence of seizures. The relationship of seizures and genetics in LGOs.Clin Neuropathol2014
25085603Rhabdoid tumor: the Irish experience 1986-2013.Cancer Genet2014
22797059Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.Oncogene2013
21796619Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas.Int J Cancer2012
22705586Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ.Exp Cell Res2012
22504026Regeneration of comparative genomic hybridization oligonucleotide microarrays with dimethylurea.Anal Biochem2012
22302800Differential DNA methylation patterns define status epilepticus and epileptic tolerance.J Neurosci2012
21860421Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.Oncogene2012
20669225Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions.Int J Cancer2011
21771658MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.Semin Cancer Biol2011
21557326Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.Mol Carcinog2011
21731748Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.PLoS One2011
21293300Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker.J Neuropathol Exp Neurol2011
21266077MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.BMC Cancer2011
20406844Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.Clin Cancer Res2010
20841484MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation.Cancer Res2010
20658962Therapeutic targeting of miRNAs in neuroblastoma.Expert Opin Ther Targets2010
20398883Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.Am J Hum Genet2010
20409325MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.Mol Cancer2010
19672776Genome-wide microarray-based comparative genomic hybridization analysis of lymphoplasmacytic lymphomas reveals heterogeneous aberrations.Leuk Lymphoma2009
19924232Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.PLoS One2009
19997598Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.PLoS One2009
17222329Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.BMC Genomics2007
16161042Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.Int J Cancer2006
16713171Analysis of copy number variation in the normal human population within a region containing complex segmental duplications on 22q11 using high-resolution array-CGH.Genomics2006
16575877Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.Genes Chromosomes Cancer2006
15805262Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.Cancer Res2005
16287142Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.Hum Mutat2005
15922827Copy-number polymorphisms: mining the tip of an iceberg.Trends Genet2005
15880457Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.Genes Chromosomes Cancer2005
15578687High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.Genes Chromosomes Cancer2005
14746990Genomic microarrays in the spotlight.Trends Genet2004
23573660Genomic microarrays in the spotlight.Drug Discov Today2004
12830322Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection.J Mol Med (Berl)2003
14556248Does chromosome 22 have anything to do with sex determination: further studies on a 46,XX,22q11.2 del male.Am J Med Genet A2003
  • 1 - 50 of 52

Recommended Authors

Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 2002
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 1
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 0
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 1
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 1
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
University of Zurich
Career Start Year 1995
Number of shared co-authors 3
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 1
Institut Curie
Career Start Year 1994
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 1
University of British Columbia
Career Start Year 1993
Number of shared co-authors 4
Institute of Neuropathology, Heinrich Heine University
Career Start Year 1993
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 3
University of California san francisco
Career Start Year 1991
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
University of British Columbia
Career Start Year 1988
Number of shared co-authors 1
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 4
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 2
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 0
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 1
Children's Cancer Research Institute, Medical University of Vienna
Career Start Year 1978
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 1

Collaborators

Royal College of Surgeons in Ireland
Co-authored papers 20
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Amsterdam University Medical Centers location AMC
Co-authored papers 4
St. Vincent's University Hospital
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Mount Sinai Hospital
Co-authored papers 2
UCD Conway Institute, University College Dublin
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Hopital Universitaire de Bruxelles - Hopital Erasme
Co-authored papers 1
McGill University, Canada Montreal Neurological Institute and Hospital
Co-authored papers 1
Institute for Genomic Medicine, Columbia University Irving Medical Center
Co-authored papers 1
Medical University of Gdansk
Co-authored papers 1
Co-authored papers 1
Department of Pharmacy, Liyang People's Hospital
Co-authored papers 1
Friedrich-Baur-Institut, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 1
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 1
St James's Hospital
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
UCL Queen Square Institute of Neurology, University College London
Co-authored papers 1
Illumina Inc. 5200 Illumina Way
Co-authored papers 1
University Hospital
Co-authored papers 1
Hospital Israelita Albert Einstein
Co-authored papers 1
University College Dublin
Co-authored papers 1